Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR) [NA]

View source ↗

Summary

A head-to-head clinical trial compared intravenous regadenoson with intravenous adenosine (Adenoscan) for measuring fractional flow reserve in patients with cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenoscan (adenosine)
  • Lexiscan (regadenoson)

Snippet

Sponsor: Ochsner Health System | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2018-05-11